458 related articles for article (PubMed ID: 15012861)
21. [Evaluation of epidemiological characteristics and risk factors of candidemia in adult patients in a tertiary-care hospital].
Yenigün Koçak B; Kuloğlu F; Doğan Çelik A; Akata F
Mikrobiyol Bul; 2011 Jul; 45(3):489-503. PubMed ID: 21935782
[TBL] [Abstract][Full Text] [Related]
22. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome.
Dimopoulos G; Ntziora F; Rachiotis G; Armaganidis A; Falagas ME
Anesth Analg; 2008 Feb; 106(2):523-9, table of contents. PubMed ID: 18227310
[TBL] [Abstract][Full Text] [Related]
23. Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation.
Gottfredsson M; Vredenburgh JJ; Xu J; Schell WA; Perfect JR
Cancer; 2003 Jul; 98(1):24-30. PubMed ID: 12833451
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study.
Garey KW; Neuhauser MM; Bearden DT; Cannon JP; Lewis RE; Gentry LO; Kontoyiannis DP
Mycoses; 2006 May; 49(3):226-31. PubMed ID: 16681815
[TBL] [Abstract][Full Text] [Related]
25. [Study on the morbidity and pathogens of patients with candidemia at the intensive care unit].
Yin QQ; Zhang YT; Fang Q
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 May; 29(5):464-8. PubMed ID: 18956679
[TBL] [Abstract][Full Text] [Related]
26. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.
Marr KA; Seidel K; White TC; Bowden RA
J Infect Dis; 2000 Jan; 181(1):309-16. PubMed ID: 10608780
[TBL] [Abstract][Full Text] [Related]
27. Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients.
Piarroux R; Grenouillet F; Balvay P; Tran V; Blasco G; Millon L; Boillot A
Crit Care Med; 2004 Dec; 32(12):2443-9. PubMed ID: 15599149
[TBL] [Abstract][Full Text] [Related]
28. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection.
Sipsas NV; Lewis RE; Tarrand J; Hachem R; Rolston KV; Raad II; Kontoyiannis DP
Cancer; 2009 Oct; 115(20):4745-52. PubMed ID: 19634156
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of candidemia in intensive care units.
Bouza E; Muñoz P
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S87-91. PubMed ID: 19013346
[TBL] [Abstract][Full Text] [Related]
30. Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit.
Faiz S; Neale B; Rios E; Campos T; Parsley E; Patel B; Ostrosky-Zeichner L
Eur J Clin Microbiol Infect Dis; 2009 Jun; 28(6):689-92. PubMed ID: 19011913
[TBL] [Abstract][Full Text] [Related]
31. Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996-2004.
Al-Tawfiq JA
Int J Infect Dis; 2007 May; 11(3):239-44. PubMed ID: 16859945
[TBL] [Abstract][Full Text] [Related]
32. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
[TBL] [Abstract][Full Text] [Related]
33. [Candidemia in an intensive care unit].
Adukauskiene D; Kinderyte A; Dambrauskiene A; Vitkauskiene A
Medicina (Kaunas); 2009; 45(5):351-6. PubMed ID: 19535880
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000.
Marchetti O; Bille J; Fluckiger U; Eggimann P; Ruef C; Garbino J; Calandra T; Glauser MP; Täuber MG; Pittet D;
Clin Infect Dis; 2004 Feb; 38(3):311-20. PubMed ID: 14727199
[TBL] [Abstract][Full Text] [Related]
35. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species.
Healy CM; Campbell JR; Zaccaria E; Baker CJ
Pediatrics; 2008 Apr; 121(4):703-10. PubMed ID: 18381534
[TBL] [Abstract][Full Text] [Related]
36. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients.
Cohen Y; Karoubi P; Adrie C; Gauzit R; Marsepoil T; Zarka D; Clec'h C
Crit Care Med; 2010 Mar; 38(3):826-30. PubMed ID: 20042858
[TBL] [Abstract][Full Text] [Related]
37. A scoring model of factors associated with Candida glabrata candidemia among critically ill patients.
Tapia GG; Razonable RR; Eckel-Passow JE; Lahr BD; Afessa B; Keegan MT; Catania J; Baddour LM
Mycoses; 2012 May; 55(3):228-36. PubMed ID: 21777296
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study.
Aguilar G; Delgado C; Corrales I; Izquierdo A; Gracia E; Moreno T; Romero E; Ferrando C; Carbonell JA; Borrás R; Navarro D; Belda FJ
BMC Res Notes; 2015 Sep; 8():491. PubMed ID: 26415526
[TBL] [Abstract][Full Text] [Related]
39. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
Garey KW; Rege M; Pai MP; Mingo DE; Suda KJ; Turpin RS; Bearden DT
Clin Infect Dis; 2006 Jul; 43(1):25-31. PubMed ID: 16758414
[TBL] [Abstract][Full Text] [Related]
40. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.
Nguyen MH; Peacock JE; Morris AJ; Tanner DC; Nguyen ML; Snydman DR; Wagener MM; Rinaldi MG; Yu VL
Am J Med; 1996 Jun; 100(6):617-23. PubMed ID: 8678081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
